Adenosine is an endogenous nucleoside that regulates many physiological and
pathological processes. It is derived from either the intracellular or extracellular …

Dipyridamole inhibits phosphodiesterase 5 (PDE5) and adenosine re-uptake. The most
prominent side-effect is headache. We examined the migraine-generating effects of …

Abstract Aim and Background Dipyridamole-induced stress myocardial perfusion scans
(MPS) has been widely used for management of coronary artery disease. The adverse …

Off-target activities of drug candidates observed during in vitro pharmacological profiling
frequently do not translate to adverse events (AEs) in human. This could be because off …

Dipyridamole has extensively been administered as a substitute for physical activity in
cardiovascular assessment. The aim of this study was to evaluate the association of …

A considerable proportion of patients discontinue dipyridamole therapy because of
headache. Risk indicators for the development of dipyridamole induced headache were …

This study is about an elderly female patient who presented with rapid atrial fibrillation.
Pharmacologic stress myocardial perfusion imaging with dipyridamole for the assessment of …

Se revisan los protocolos de cardiología nuclear actuales, con énfasis en los estudios
tomográficos de fotón único (" SPECT") de perfusión miocárdica principalmente en …

Evidence of a link between headache symptoms and cardiovascular disease has rapidly
grown in recent years and it is of utmost importance for the cardiologist and neurologist to be …

Objective Regadenoson is the first Food and Drug Administration-approved selective A2A
adenosine receptor agonist used in myocardial perfusion imaging. Its main benefits are its …